Wolf Theiss, working with Italian offices of Dentons, has advised the shareholders of Lifebrain, an Italian laboratory diagnostics services operator, on the cross-border sale of its shares to an investment subsidiary of Investindustrial VI L.P. Investindustria, which was advised by Italy's Chiomenti law firm, with CHSH acting as local counsel for Austria, now owns 96% of Lifebrain.
According to Wolf Theiss, “the Vienna-headquartered Lifebrain is, through its subsidiaries, a leading routine and specialty laboratory testing operator with approximately 220 laboratories across Italy, performing more than 20 million tests annually and serving more than 200 health care facilities.”
The product portfolio of Lifebrain includes seven main product segments in the field of laboratory diagnostics services: clinical chemistry, hematology, immunochemistry, microbiology, molecular biology, cytology, and pathology. Lifebrain generates revenues in excess of EUR 100 million.
The Wolf Theiss team included Partner Dieter Spranz, Counsels Carolin Ziegler and Jochen Anweiler, and Senior Associates Clara Gordon and Ivo Stitic.
The CHSH team included Partners Johannes Aehrenthal, Johannes Prinz, Thomas Zivny, and Bernhard Kofler-Senoner, Counsel Michael Mayer, Senior Attorney Jakob Hartig, Attorney Stefanie Heimel, Associates Florian Wunscher, Alexander Gruber, Ferdinand Guggenmos, and Katharina Wilding.
